White Paper:

An Overview of Cross-Border Collaborations on HTA, Pricing Negotiation, & Procurement

In this paper, we explore a range of recent cross border collaborations in Europe that will affect the European market access environment.  These include:

  1. Small groups of countries conducting joint healthcare technology assessment (HTA) and price negotiations
  2. Increased official or unofficial price referencing
  3. EU-wide initiatives, e.g., HTA harmonization, evidence generation requirements, real world evidence (RWE)

In particular, we outline their progress to date, their likely future impact, and potential implications for biopharma companies.

Download
  • Hidden
  • This field is for validation purposes and should be left unchanged.